EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 397 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $27,077 | +37.2% | 1,395 | +13.4% | 0.00% | – |
Q4 2022 | $19,729 | +3.8% | 1,230 | 0.0% | 0.00% | – |
Q3 2022 | $19,000 | -26.9% | 1,230 | 0.0% | 0.00% | – |
Q2 2022 | $26,000 | -3.7% | 1,230 | +2.5% | 0.00% | – |
Q1 2022 | $27,000 | +22.7% | 1,200 | 0.0% | 0.00% | – |
Q4 2021 | $22,000 | -12.0% | 1,200 | 0.0% | 0.00% | – |
Q3 2021 | $25,000 | -73.1% | 1,200 | -92.5% | 0.00% | – |
Q3 2013 | $93,000 | +29.2% | 15,912 | 0.0% | 0.00% | – |
Q2 2013 | $72,000 | – | 15,912 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |